Migraine With Aura Completed Phase 1 Trials for Dihydroergotamine (DB00320)

Also known as: Aura Migraine / Migraine with Auras / Basilar migraine / Migraine aura

IndicationStatusPhase
DBCOND0031385 (Migraine With Aura)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03874832A Phase I Study to Study the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy SubjectsTreatment